Provided by Tiger Trade Technology Pte. Ltd.

Protalix BioTherapeutics

2.09
-0.0750-3.47%
Volume:280.50K
Turnover:589.25K
Market Cap:167.68M
PE:-25.44
High:2.14
Open:2.14
Low:2.06
Close:2.16
52wk High:3.19
52wk Low:1.32
Shares:80.42M
Float Shares:60.76M
Volume Ratio:0.74
T/O Rate:0.46%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.0820
EPS(LYR):-0.0841
ROE:-14.44%
ROA:-4.41%
PB:3.48
PE(LYR):-24.80

Loading ...

Feb 13, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 10, 2020

Major Issues Report

Current report, items 7.01 and 9.01
Feb 07, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 06, 2020

Major Issues Report

Current report, items 8.01 and 9.01
Dec 20, 2019

Major Issues Report

Current report, items 3.03, 5.03, and 9.01
Dec 19, 2019

Major Issues Report

Current report, items 5.02 and 9.01
Dec 09, 2019

Major Issues Report

Current report, items 5.07, 8.01, and 9.01
Nov 18, 2019

Major Issues Report

Current report, items 8.01 and 9.01
Nov 07, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Nov 07, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Oct 17, 2019

Major Issues Report

Current report, items 8.01 and 9.01
Sep 24, 2019

Major Issues Report

Current report, items 8.01 and 9.01
Aug 30, 2019

Major Issues Report

Current report, items 3.01 and 9.01
Aug 13, 2019

Major Issues Report

Current report, items 5.02 and 9.01
Aug 08, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Aug 08, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Jul 29, 2019

Major Issues Report

Current report, items 1.01, 5.02, and 9.01
Jul 22, 2019

Major Issues Report

Current report, item 5.02
Jul 02, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jul 02, 2019

Statement Of Changes In Beneficial Ownership

Initial statement of beneficial ownership of securities